23 G X 1 IN. BD ECLIPSE¿ 3 ML BD LUER-LOK¿ SYRINGE WITH DETACHABLE NEEDLE
Report
- Report Number
- 8041187-2017-00118
- Event Type
- Malfunction
- Date Received
- September 25, 2017
- Date of Event
- July 31, 2017
- Report Date
- October 24, 2017
- Manufacturer
- BECTON DICKINSON MEDICAL (SINGAPORE)
- Product Code
- FMI
- PMA / PMN Number
- K161170
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TW
- Reporter Occupation
- OTHER
Narratives
INVESTIGATION SUMMARY: ONE PICTURE RECEIVED AND ONE ACTUAL SAMPLE WITHOUT PACKAGING WAS RETURNED FOR INVESTIGATION. OBSERVED THE SYRINGE BARREL WAS DAMAGED. DHR REVIEW: NO ABNORMALITY AND QN REPORTED DURING ECLIPSE ASSEMBLY PRODUCTION. REVIEWED SYRINGE DHR FOR CATALOGUE# S20351SGT, BATCH# 7142288, 7087209, 7108087, 7142041, 7115368. NO QUALITY NOTIFICATION WAS RAISED FOR ALL THE BATCHES ON THE REPORTED NONCONFORMANCE. NO SIMILAR NONCONFORMANCE WAS DETECTED IN IN-PROCESS AND OUTGOING INSPECTION. INVESTIGATION CONCLUSION: ONE PICTURE AND ONE ACTUAL SAMPLE WITHOUT PACKAGING RECEIVED. WE OBSERVED DAMAGE ON THE SYRINGE BARREL. ROOT CAUSE DESCRIPTION: PROBABLE CAUSE COULD BE DUE TO POOR THROW OUT OF THE ASSEMBLED SYRINGE AT THE AUTO-REJECT STATION. THE BARREL COULD HAVE BEEN SLANTED AND HIT THE SIDE GUIDE RESULTING IN DAMAGE BARREL. CAPA# (B)(4) HAD BEEN INITIATED TO ADDRESS DAMAGED SYRINGE NONCONFORMANCE.
A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. (B)(4).
IT AS REPORTED THAT THE BARREL ON A 23 G X 1 IN. BD ECLIPSE¿ 3 ML BD LUER-LOK¿ SYRINGE WITH DETACHABLE NEEDLE WAS CRACKED WHICH COULD LEAD TO LEAKAGE. NO INJURY OR MEDICAL INTERVENTION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 670890 | 23 G X 1 IN. BD ECLIPSE¿ 3 ML BD LUER-LOK¿ SYRINGE WITH DETACHABLE NEEDLE | SAFETY ENGINEERED SYRINGE AND NEEDLE | FMI | BECTON DICKINSON MEDICAL (SINGAPORE) | 7135159 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |